Табакокурение и ревматоидный артрит

  • Авторы: Хохлова Ю.В.1, Лесняк О.М.2, Инамова О.В.3,4, Петрова М.С.3,4
  • Учреждения:
    1. СЗГМУ им. И.И.Мечникова, Санкт-Петербург, СПБ ГБУЗ «Клиническая ревматологическая больница № 25, Санкт-Петербург
    2. Северо-Западный государственный медицинский университет им. Мечникова
    3. ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России
    4. СПб ГБУЗ «Клиническая ревматологическая больница № 25»
  • Раздел: Научный обзор
  • URL: https://journals.eco-vector.com/RFD/article/view/625754
  • DOI: https://doi.org/10.17816/RFD625754
  • ID: 625754


Цитировать

Полный текст

Аннотация

Ревматоидный артрит (РА) - хроническое воспалительное заболевание, вызываемое как генетическими факторами, так и факторами окружающей среды. Курение считается одним из наиболее важных внешних факторов риска его развития и тяжести, а также ассоциируется с быстрым прогрессированием заболевания и неудовлетворительным ответом на лечение, что определяет важность изучения данной проблемы среди пациентов с РА для выявления барьеров в отказе от курения и факторов, способствующих прекращению употребления табака, а также для разработки специфичных для пациентов с РА программ по отказу от курения.

Полный текст

Доступ закрыт

Об авторах

Юлия Владимировна Хохлова

СЗГМУ им. И.И.Мечникова, Санкт-Петербург,
СПБ ГБУЗ «Клиническая ревматологическая больница № 25, Санкт-Петербург

Автор, ответственный за переписку.
Email: julia-khokhlova@mail.ru
ORCID iD: 0000-0002-3902-4873
SPIN-код: 2926-1461

аспирант кафедры семейной медицины СЗГМУ им. И.И.Мечникова, Санкт-Петербург, врач-ревматолог СПБ ГБУЗ «Клиническая ревматологическая больница № 25, Санкт-Петербург

Россия

Ольга Михайловна Лесняк

Северо-Западный государственный медицинский университет им. Мечникова

Email: olga.m.lesnyak@yandex.ru
ORCID iD: 0000-0002-0143-0614
SPIN-код: 6432-4188

д-р мед. наук, профессор

Россия, 191015, Санкт-Петербург, ул. Кирочная, д. 41

Оксана Владимировна Инамова

ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России; СПб ГБУЗ «Клиническая ревматологическая больница № 25»

Email: ovig74@mail.ru
ORCID iD: 0000-0001-9126-3639

кандидат медицинских наук , зам. директора НИИ ревматологии, ассистент кафедры терапии, ревматологии, экспертизы временной нетрудоспособности и качества медицинской помощи им. Э.Э. Эйхвальда, главный врач СПб ГБУЗ «КРБ №25»

Россия, 191014, Санкт-Петербург, ул. Кирочная, д. 41; Санкт-Петербург

Марианна Семеновна Петрова

ФГБОУ ВО «Северо-Западный государственный медицинский университет им. И.И. Мечникова» Минздрава России; СПб ГБУЗ «Клиническая ревматологическая больница № 25»

Email: podagra@bk.ru
ORCID iD: 0000-0001-5261-6614

кандидат медицинских наук, доцент кафедры терапии, ревматологии, экспертизы временной нетрудоспособности и качества медицинской помощи им. Э.Э. Эйхвальда, зам. главного врача СПб ГБУЗ «КРБ №25»

Россия, 191014, Санкт-Петербург, ул. Кирочная, д. 41; Санкт-Петербург

Список литературы

  1. Who.int [интернет]. Доклад ВОЗ о глобальной табачной эпидемии, 2021 г.: pешение проблемы новых и появляющихся изделий [дата обращения: 11.02.2023]. Доступ по ссылке: https://www.who.int/europe/ru/publications/i/item/9789240032095
  2. Wciom.ru [интернет]. Курение в России: мониторинг [дата обращения: 11.02.2023]. Доступ по ссылке: https://wciom.ru/analytical-reviews/analiticheskii-obzor/kurenie-v-rossii-monitoring-2022
  3. Андреева Е.А., Похазникова М.А., Кузнецова О.Ю. Распространенность курения среди жителей двух городов СевероЗападного региона России по данным международного исследования «РЕСПЕКТ» // Профилактическая медицина 2020, Т. 23, №1, с. 92-99 https://doi.org/10.17116/profmed20202301192
  4. McInnes I.B., Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis // Lancet (London, England). 2017. Vol.389, N 10086. P. 2328–2337. https://doi.org/10.1016/S0140-6736(17)31472-1
  5. Gwinnutt J.M., Verstappen S.M., Humphreys J.H. The impact of lifestyle behaviours, physical activity and smoking on morbidity and mortality in patients with rheumatoid arthritis // Best practice & research. Clinical rheumatology. 2020 . Vol.34, N 2. P. 101562. https://doi.org/10.1016/j.berh.2020.101562
  6. Di Giuseppe D., Discacciati A., Orsini N., et al. Cigarette smoking and risk of rheumatoid arthritis: a dose-response meta-analysis // Arthritis research & therapy. 2014. Vol.16, N 2. P.61. https://doi.org/10.1186/ar4498
  7. Hedström A.K., Stawiarz L., Klareskog L., et al. Smoking and susceptibility to rheumatoid arthritis in a Swedish population-based case-control study //European journal of epidemiology. 2018. Vol.33, N 4. P.415–423. https://doi.org/10.1007/s10654-018-0360-5
  8. Zhao S.S., Holmes M.V., Zheng J., et al. The impact of education inequality on rheumatoid arthritis risk is mediated by smoking and body mass index: Mendelian randomization study //Rheumatology (Oxford, England).2022. Vol.61, N 5. P. 2167–2175. https://doi.org/10.1093/rheumatology/keab654
  9. Seror R., Henry J., Gusto G., et al. Passive smoking in childhood increases the risk of developing rheumatoid arthritis // Rheumatology (Oxford, England). 2019. Vol.58, N 7. P.1154–1162. https://doi.org/10.1093/rheumatology/key219
  10. Kim S.K., Choe J.Y. Passive Smoking is Responsible for Disease Activity in Female Patients With Rheumatoid Arthritis // Archives of rheumatology. 2017. Vol.33, N 2. P.143–149. https://doi.org/10.5606/ArchRheumatol.2018.6468
  11. Hedström A.K., Klareskog L., Alfredsson L. Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study // Annals of the rheumatic diseases. 2018. Vol.77 N 7. P. 970–972. https://doi.org/10.1136/annrheumdis-2018-212973
  12. Glossop J.R., Dawes P.T., Mattey D.L. Association between cigarette smoking and release of tumour necrosis factor alpha and its soluble receptors by peripheral blood mononuclear cells in patients with rheumatoid arthritis // Rheumatology (Oxford, England). 2006. Vol.45 N 10. P. 1223–1229. https://doi.org/10.1093/rheumatology/kel094
  13. Reyes-Pérez I.V., Sánchez-Hernández P.E., Muñoz-Valle J.F., et al. Cytokines (IL-15, IL-21, and IFN-γ) in rheumatoid arthritis: association with positivity to autoantibodies (RF, anti-CCP, anti-MCV, and anti-PADI4) and clinical activity // Clinical rheumatology. 2019. Vol.38 N 11. P. 3061–3071. https://doi.org/10.1007/s10067-019-04681-4
  14. Ishikawa Y., Ikari K., Hashimoto M., et al. Shared epitope defines distinct associations of cigarette smoking with levels of anticitrullinated protein antibody and rheumatoid factor // Annals of the rheumatic diseases. 2019. Vol.78 N 11. P.1480–1487. https://doi.org/10.1136/annrheumdis-2019-215463
  15. Klareskog L., Stolt P., Lundberg K., et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination // Arthritis and rheumatism. 2006. Vol.54 N 1. P. 38–46. https://doi.org/10.1002/art.21575
  16. van Wesemael T.J., Ajeganova S., Humphreys J., et al. Smoking is associated with the concurrent presence of multiple autoantibodies in rheumatoid arthritis rather than with anti-citrullinated protein antibodies per se: a multicenter cohort study // Arthritis research & therapy. 2016. Vol.18 N 1. P. 285. https://doi.org/10.1186/s13075-016-1177-9
  17. Bracke K., Cataldo D., Maes T., et al. Matrix metalloproteinase-12 and cathepsin D expression in pulmonary macrophages and dendritic cells of cigarette smoke-exposed mice // International archives of allergy and immunology. 2005. Vol.138 N 2. P.169–179. https://doi.org/10.1159/000088439
  18. Liu Y., Aryee M.J., Padyukov L., et al. P. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis // Nature biotechnology. 2013. Vol.31 N 2. P.142–147. https://doi.org/10.1038/nbt.2487
  19. Raitio A., Tuomas H., Kokkonen N., et al. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers // Archives of dermatological research. 2005. Vol.297 N 6. P. 242–248. https://doi.org/10.1007/s00403-005-0597-1
  20. Xue M., McKelvey K., Shen K., et al. Endogenous MMP-9 and not MMP-2 promotes rheumatoid synovial fibroblast survival, inflammation and cartilage degradation // Rheumatology (Oxford, England). 2014. Vol.53 N 12. P. 2270–2279. https://doi.org/10.1093/rheumatology/keu254
  21. Zhuo J., Xia, Q., Sharma N., et al. The Role of Shared Epitope in Rheumatoid Arthritis Prognosis in Relation to Anti-Citrullinated Protein Antibody Positivity // Rheumatology and therapy. 2022. Vol.9 N 2. P. 637–647. https://doi.org/10.1007/s40744-022-00427-y
  22. Hedström A.K., Rönnelid J., Klareskog L., et al. Complex Relationships of Smoking, HLA-DRB1 Genes, and Serologic Profiles in Patients With Early Rheumatoid Arthritis: Update From a Swedish Population-Based Case-Control Study // Arthritis & rheumatology (Hoboken, N.J.). 2019. Vol.71 N 9. P.1504–1511. https://doi.org/10.1002/art.40852
  23. Karami J., Aslani S., Jamshidi A., et al. Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review // Gene. 2019. Vol.702 P. 8–16. https://doi.org/10.1016/j.gene.2019.03.033
  24. Westra H.J., Martínez-Bonet M., Onengut-Gumuscu S., et al. Fine-mapping and functional studies highlight potential causal variants for rheumatoid arthritis and type 1 diabetes // Nature genetics. 2018. Vol.50 N 110. P.1366–1374. https://doi.org/10.1038/s41588-018-0216-7
  25. Mahdi H., Fisher B.A., Källberg H., et al. Specific interaction between genotype, smoking and autoimmunity to citrullinated alpha-enolase in the etiology of rheumatoid arthritis // Nature genetics. 2009. Vol.41 N 12. P. 1319–1324. https://doi.org/10.1038/ng.480
  26. Lundberg K., Bengtsson C., Kharlamova N., et al. Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile // Annals of the rheumatic diseases. 2013. Vol.72 N 5. P.652–658. https://doi.org/10.1136/annrheumdis-2012-201484
  27. Kochi Y., Thabet M.M., Suzuki A., et al. PADI4 polymorphism predisposes male smokers to rheumatoid arthritis // Annals of the rheumatic diseases. 2011. Vol.70 N3. P.512–515. https://doi.org/10.1136/ard.2010.130526
  28. Massarenti L., Enevold C., Damgaard D., et al. PADI4 Polymorphisms Confer Risk of Anti-CCP-Positive Rheumatoid Arthritis in Synergy With HLA-DRB1*04 and Smoking // Frontiers in immunology. 2021. Vol.12 P. 707690. https://doi.org/10.3389/fimmu.2021.707690
  29. Demoruelle M.K., Weisman M.H., Simonian P.L., et al. Brief report: airways abnormalities and rheumatoid arthritis-related autoantibodies in subjects without arthritis: early injury or initiating site of autoimmunity? // Arthritis and rheumatism. 2012. Vol.64 N 6. P.1756–1761. https://doi.org/10.1002/art.34344
  30. Klareskog L., Gregersen P.K., Huizinga T.W. Prevention of autoimmune rheumatic disease: state of the art and future perspectives // Annals of the rheumatic diseases. 2010. Vol.69 N 12. P. 2062–2066. https://doi.org/10.1136/ard.2010.142109
  31. Vesperini V., Lukas C., Fautrel B., et al. Association of tobacco exposure and reduction of radiographic progression in early rheumatoid arthritis: results from a French multicenter cohort // Arthritis care & research. 2013. Vol.65 N 12. P.1899–1906. https://doi.org/10.1002/acr.22057
  32. Roelsgaard I.K., Ikdahl E., Rollefstad S., et al. Smoking cessation is associated with lower disease activity and predicts cardiovascular risk reduction in rheumatoid arthritis patients // Rheumatology (Oxford, England). 2020. Vol.59 N 8. P.1997–2004. https://doi.org/10.1093/rheumatology/kez557
  33. Andersson M.L.E., Forslind K., Hafström I., et al. Patients with Early Rheumatoid Arthritis in the 2000s Have Equal Disability and Pain Despite Less Disease Activity Compared with the 1990s: Data from the BARFOT Study over 8 Years // The Journal of rheumatology. 2017. Vol.44 N 6. P.723–731. https://doi.org/10.3899/jrheum.161235
  34. Naranjo A., Toloza S., Guimaraes da Silveira I., et al. Smokers and non smokers with rheumatoid arthritis have similar clinical status: data from the multinational QUEST-RA database // Clinical and experimental rheumatology. 2010. Vol.28 N 6. P. 820–827.
  35. Nyhäll-Wåhlin B.M., Petersson I.F., Nilsson J.A., et al. High disease activity disability burden and smoking predict severe extra-articular manifestations in early rheumatoid arthritis // Rheumatology (Oxford, England). 2009. Vol.48 N 4. P.416–420. https://doi.org/10.1093/rheumatology/kep004
  36. Turesson C., Schaid D.J., Weyand C.M., et al. Association of HLA-C3 and smoking with vasculitis in patients with rheumatoid arthritis //Arthritis and rheumatism. 2006. Vol.54 N 9. P.2776–2783. https://doi.org/10.1002/art.22057
  37. Kelly C.A., Saravanan V., Nisar M., et al. Rheumatoid arthritis-related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics--a large multicentre UK study // Rheumatology (Oxford, England). 2014. Vol.53 N 9. P.1676–1682. https://doi.org/10.1093/rheumatology/keu165
  38. Wheeler A.M., Baker J.F., Poole J.A., et al. Genetic, social, and environmental risk factors in rheumatoid arthritis-associated interstitial lung disease // Seminars in arthritis and rheumatism. 2010. Vol.57 P.152098. https://doi.org/10.1016/j.semarthrit.2022.152098.
  39. de Rooy D.P., van Nies J.A., Kapetanovic M.C., et al. Smoking as a risk factor for the radiological severity of rheumatoid arthritis: a study on six cohorts // Annals of the rheumatic diseases. 2014. Vol.73 N7. P.1384–1387. https://doi.org/10.1136/annrheumdis-2013-203940
  40. Nayebirad S., Javinani A., Javadi M., et al. The effect of smoking on response to methotrexate in rheumatoid arthritis patients: A systematic review and meta-analysis // Modern rheumatology. 2023. Vol.34 N 1. P. 68–78. https://doi.org/10.1093/mr/road013
  41. Söderlin M.K., Petersson I.F., Geborek P. The effect of smoking on response and drug survival in rheumatoid arthritis patients treated with their first anti-TNF drug // Scandinavian journal of rheumatology. 2012. Vol.41 N1. P.1–9. https://doi.org/10.3109/03009742.2011.599073
  42. Levitsky A., Brismar K., Hafström I., et al. Obesity is a strong predictor of worse clinical outcomes and treatment responses in early rheumatoid arthritis: results from the SWEFOT trial // RMD open. 2017. Vol.3 N 2. P.e000458. https://doi.org/10.1136/rmdopen-2017-000458
  43. Potter C., Hyrich K.L., Tracey A., et al. Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis // Annals of the rheumatic diseases.2009. Vol.68 N 1. P.69–74. https://doi.org/10.1136/ard.2007.084715
  44. Braun-Moscovici Y., Markovits D., Zinder O., et al. Anti-cyclic citrullinated protein antibodies as a predictor of response to anti-tumor necrosis factor-alpha therapy in patients with rheumatoid arthritis // The Journal of rheumatology. 2006. Vol.33 N 3. P.497–500.
  45. Metsios G.S., Stavropoulos-Kalinoglou A., Nevill A.M., et al. Cigarette smoking significantly increases basal metabolic rate in patients with rheumatoid arthritis // Annals of the rheumatic diseases. 2008. Vol.67 N 1. P. 70–73. https://doi.org/10.1136/ard.2006.068403
  46. Wolbink G.J., Vis, M., Lems W., et al. Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis // Arthritis and rheumatism. 2010. Vol.54 N 3. P.711–715. https://doi.org/10.1002/art.21671
  47. Liu X., Tedeschi S.K., Barbhaiya M., et al. Impact and Timing of Smoking Cessation on Reducing Risk of Rheumatoid Arthritis Among Women in the Nurses' Health Studies // Arthritis care & research. 2019. Vol.71 N 7. P.914–924. https://doi.org/10.1002/acr.23837
  48. Fisher M.C., Hochberg M. C., El-Taha M., et al. Smoking, smoking cessation, and disease activity in a large cohort of patients with rheumatoid arthritis // The Journal of rheumatology. 2012. Vol.39 N 5. P. 904–909. https://doi.org/10.3899/jrheum.110852
  49. Andersson M.L., Bergman S., Söderlin M.K. The Effect of Stopping Smoking on Disease Activity in Rheumatoid Arthritis (RA). Data from BARFOT, a Multicenter Study of Early RA // The open rheumatology journal. 2012. Vol.6 P. 303–309. https://doi.org/10.2174/1874312901206010303
  50. Baghdadi L.R., Woodman R.J., Shanahan E.M., et al. The impact of traditional cardiovascular risk factors on cardiovascular outcomes in patients with rheumatoid arthritis: a systematic review and meta-analysis // PloS one. 2015. Vol.10 N 2. P.e0117952. https://doi.org/10.1371/journal.pone.0117952
  51. Zhu D., Zhao G., Wang X. Association of Smoking and Smoking Cessation With Overall and Cause-Specific Mortality // American journal of preventive medicine. 2021. Vol.60 N 4. P. 504–512. https://doi.org/10.1016/j.amepre.2020.11.003
  52. Naranjo A., Bilbao A., Erausquin C., et al. Results of a specific smoking cessation program for patients with arthritis in a rheumatology clinic // Rheumatology international. 2014. Vol.34 N 1. P. 93–99. https://doi.org/10.1007/s00296-013-2851-8
  53. Aimer P., Treharne G.J., Stebbings S., et al. Efficacy of a Rheumatoid Arthritis-Specific Smoking Cessation Program: A Randomized Controlled Pilot Trial // Arthritis care & research. 2017. Vol.69 N 1. P. 28–37. https://doi.org/10.1002/acr.22960
  54. Lopez-Olivo M.A., Sharma G., Singh G., et al. A systematic review with meta-analysis of the effects of smoking cessation strategies in patients with rheumatoid arthritis // PloS one . 2022. Vol.17 N 12. P. e0279065. https://doi.org/10.1371/journal.pone.0279065
  55. Schletzbaum M., Wang X., Greenlee R., et al. Predictors of Smoking Cessation in Patients With Rheumatoid Arthritis in Two Cohorts: Most Predictive Health Care Factors // Arthritis care & research. 2021. Vol.73 N 5. P. 633–639. https://doi.org/10.1002/acr.24154
  56. Gath M.E., Stamp L.K., Aimer P., et al. Reconceptualizing motivation for smoking cessation among people with rheumatoid arthritis as incentives and facilitators // Musculoskeletal care. 2018. Vol.16 N 1. P.139–146. https://doi.org/10.1002/msc.1227
  57. Wattiaux A., Bettendorf B., Block L., et al. Patient Perspectives on Smoking Cessation and Interventions in Rheumatology Clinics // Arthritis care & research. 2020. Vol.72 N 3. P.369–377. https://doi.org/10.1002/acr.23858
  58. Laugesen M., Rasmussen M., Christensen R., et al. Smoking Cessation Rates among Patients with Rheumatoid Arthritis and Osteoarthritis Following the 'Gold Standard Programme' (GSP): A Prospective Analysis from the Danish Smoking Cessation Database // International journal of environmental research and public health. 2022. Vol.19 N 10. P. 5815. https://doi.org/10.3390/ijerph19105815
  59. Chow E., Williams M., Giri B., et al. Strategies to reduce the impact of smoking on rheumatoid arthritis outcomes: Clinical experience of a brief outpatient clinic screening questionnaire. Comment on "The impact of smoking on rheumatoid arthritis outcomes." By Vittecoq et al. Joint Bone Spine 2018;85:135-138 // Joint bone spine. 2019. Vol.86 N 2. P. 275. https://doi.org/10.1016/j.jbspin.2018.09.012
  60. Karacabeyli D., Shojania K., Dehghan N., et al. Rheumatology health care providers' views and practices on obesity and smoking cessation management in rheumatoid arthritis // Clinical rheumatology. 2021. Vol.40 N 7. P.2681–2688. https://doi.org/10.1007/s10067-021-05607-9

Дополнительные файлы

Доп. файлы
Действие
1. JATS XML
Скачать

© Эко-Вектор,


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 70763 от 21.08.2017 г.


Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах